Moran Wealth Management, LLC Incyte Corp Transaction History

Moran Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$52.16 - $64.19 $2.99 Million - $3.69 Million	-57,414 Reduced 44.55%	71,451 $4.49 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $36,048 - $41,140	624 Added 0.49%	128,865 $7.44 Million
Q2 2023 Aug 10, 2023	BUY	$60.95 - $75.51 $266,290 - $329,903	4,369 Added 3.53%	128,241 $7.98 Million
Q1 2023 May 10, 2023	BUY	$70.23 - $86.01 $273,897 - $335,439	3,900 Added 3.25%	123,872 $8.95 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $8.06 Million - $10.1 Million	119,972 New	119,972 $0

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moran Wealth Management, LLC with notifications on news.